Severe Covid-19 Doubles Risk Of Death In The Year After Illness

Survivors of severe Covid-19 are more than twice as likely to die over the following year than those who experienced milder symptoms or remained uninfected, according to new research published in Frontiers in Medicine, suggesting serious infections may cause significant damage to long-term health and underscoring the protection offered by vaccines. The risk following severe infection was particularly noteworthy in patients under 65, who had a 233% increased chance of dying compared to the uninfected, the researchers found. The increased risk of death for under 65s with severe Covid-19 was greater than that for those over the age of 65, the researchers found.

The research, by academics at the University of Florida, was based on an analysis of the electronic health records of 13,638 patients who underwent a PCR test for coronavirus within the University of Florida health system and recovered from the disease. The vast majority of patients—80%did not die from complications typically associated with Covid-19 like blood clotting or respiratory failure and died long after the initial infection had passed, the researchers said, meaning their deaths may never have been linked to Covid-19 by families or doctors. The findings suggest severe infection damages overall health and leaves patients vulnerable to other health issues, the researchers wrote, highlighting the importance of preventing serious illness through vaccination.

Patients with severe Covid-19 who recoveredwere at significantly greater risk of being hospitalized in the subsequent six months” said Arch Mainous, a professor at the University of Florida and the study’s lead author. “We must be especially vigilant in decreasing severe episodes of Covid-19” now we know it comes with a “substantial risk of dying from what would likely be considered to be an unrecognized complication… Taking your chances and hoping for successful treatment in the hospital doesn’t convey the full picture of the impact of Covid-19.”

While not able to prevent all infections, Covid-19 vaccines drastically cut the odds of severe illness and hospitalization in breakthrough cases. The vast majority of deaths from Covid-19 have been among the unvaccinated and hospitals in parts of the country have been pushed to their limits with a deluge of unvaccinated Covid-19 patients. Nearly a year after vaccines became freely and widely available in wealthy countries, leaders still lament the “pandemic of the unvaccinated” amid poor uptake and a resurgence of cases. Placing the immediate risk of Covid-19, this research supports a growing body of evidence outlining the persistent and sometimes new symptoms some coronavirus patients experience for weeks or months after their initial infection. The list of potentially debilitating symptoms for long Covid is long—one study identifies over 200—and covers the entire body, ranging from memory loss and hallucinations to tremors, fatigue and digestive issues. Research suggests that one in five Covid-19 patients will go on to be diagnosed with a mental illness within three months of recovery and conditions affecting the brain and thinking arecommon. Vaccines also appear to slash the risks of developing long Covidstudies suggest, though the precise mechanism of this is not yet understood, aside from preventing infection in the first place.

Source: https://www.frontiersin.org/
AND
https://www.forbes.com/

Amazon is now selling COVID-19 tests for customers to use at home

The DxTerity COVID-19 Saliva at-Home Collection Kit detects the presence of the virus but does not confirm immunity or detect antibodies. DxTerity‘s molecular-based PCR test received approval from the Food and Drug Administration last month. The test differs from the quicker and less expensive antigen tests, which use a nasal swab or throat swab to detect the virus.

A single COVID-19 testing kit is listed for $110, and a 10-pack bundle is available for $1,000.

Test takers must spit into a tube provided by the kit. The saliva sample is then inserted into a plastic bag and packed back into the box for shipment to one of DxTerity‘s laboratories certified by the Clinical Laboratory Improvement Amendments. Customers are also granted prepaid express return shipping with the test and should expect to receive results within 24 to 72 hours of sample receipt at the laboratory. DxTerity’s test is currently the only COVID-19 testing kit on Amazon.

CLICK ON THE IMAGE TO ENJOY THE VIDEO

We have demonstrated the reliability and quality of our COVID-19 testing solution with big business and now we want to expand access to customers at home and small businesses,” said Bob Terbrueggen, founder and CEO of DxTerity, when he first announced the collaboration with the company last month. “Amazon is the perfect partner for expanding access to millions of U.S. customers.”

The test may not be valid for all travel purposes because sample collection is unsupervised, according to the product description. The Centers for Disease Control and Prevention recommends saliva specimens should be collected under supervision.

Amazon joins other retail giants in offering at-home COVID-19 saliva tests. Costco offers both regular and those approved for travel requirements to Hawaii, Bermuda and some other destinations for $129.99 and $139.99, respectively. However, the test has several dozen one-star reviews, with most complaining about delayed shipping and poor customer service from provider AZOVA.

Source: https://eu.usatoday.com/